A Randomized Controlled Study of Digitalized Cognitive-behavioral Intervention for Childhood Anxiety

February 16, 2024 updated by: Andre Sourander, University of Turku

Digitalized Cognitive-behavioral Intervention for Anxiety Among School Children. A Randomized Controlled Study

The aim of the study is to evaluate the effectiveness of a digitalized cognitive-behavioral treatment for anxiety among school aged children. The participants are screened from the general population, as a part of the routine school health care check-ups. Half of the children with anxiety will receive the digitalized treatment program, while the other half will receive education about anxiety in internet.

Study Overview

Study Type

Interventional

Enrollment (Actual)

465

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Turku, Finland, 20500
        • Child Psychiatric Research Center, University of Turku

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

- Scoring ≥22 on SCARED

Exclusion Criteria:

  • no access to internet
  • insufficient language (Finnish until summer 2019, Finnish and Swedish from autumn 2019 onwards, when also Swedish version of the intervention was available) skills
  • visual or hearing impairment that hinders the use of the program
  • the child's mental retardation, autism spectrum disorder, suicidal intentions or severe mental disorder
  • the child's psychotherapy (ongoing or starting within 6 months)
  • the child's medication (for anxiety) started / changed within 2 months
  • current involvement with child protection services (i.e., removal of child custody, investigation of child abuse or neglect)
  • parent's severe psychiatric / somatic disease or other reason that hinders the parent to actively participate in the program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Digitalized cognitive-behavioral intervention
An internet-based CBT, including telephone coaching
Active Comparator: Psychoeducation about anxiety
Psychoeducative material about anxiety in internet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline to 6 months follow up; the Screen for Child Anxiety Related Disorders - child and parent reports
Time Frame: Change from baseline to 6 months follow up; symptoms during the last three months
Comprises of 41 items assessing symptoms of general anxiety, separation anxiety, panic disorder, social anxiety, and school phobia; scoring 0-82 (higher score meaning more symptoms)
Change from baseline to 6 months follow up; symptoms during the last three months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline to 6 months follow up; the Child Anxiety Impact Scale - child and parent reports
Time Frame: Change from baseline to 6 months follow up; impact of anxiety during the last month
Comprises of 27 items assessing the impact of anxiety on the daily life of the children at home, school and with friends; scoring 0-81 (higher score meaning higher impact of anxiety)
Change from baseline to 6 months follow up; impact of anxiety during the last month
Change from Baseline to 6 months follow up (in the Intervention group); the Development and Well-Being Assessment - child and parent reports
Time Frame: Change from baseline to 6 months follow up; varying time windows for different diagnoses
A diagnostic interview to assess anxiety disorders among 2-17-year-old children
Change from baseline to 6 months follow up; varying time windows for different diagnoses
Change from Baseline to 6 months follow up; the Revised Children Quality of Life - Questionnaire - child and parent reports
Time Frame: Change from baseline to 6 months follow up; QoL during the last week
Comprises of 24 items assessing the health-related quality of life divided into six subscales: physical, psychological, self-esteem, family, social life, and school; scoring 24-96 (higher score meaning higher QoL)
Change from baseline to 6 months follow up; QoL during the last week
Change from Baseline to 6 months follow up; the Child Depression inventory - child report
Time Frame: Change from baseline to 6 months follow up; symptoms during the last two weeks
Comprises of 28 items assessing the child's depressive symptoms; scoring 0-54 (higher score meaning more symptoms)
Change from baseline to 6 months follow up; symptoms during the last two weeks
Change from Baseline to 6 months follow up; the Strengths and Difficulties Questionnaire, extended version - parent report
Time Frame: Change from baseline to 6 months follow up; symptoms during the last six months
Comprises of 25 items assessing the child's psychiatric symptoms and positive attributes, and an impact supplement; scoring 0-40 (prosocial scale is not included in the total score) (higher score meaning more problems)
Change from baseline to 6 months follow up; symptoms during the last six months
Change from Baseline to 6 months follow up of the relations with peers and school (not a standardized scale)
Time Frame: Change from baseline to 6 months follow up
Experience of being bullied (traditional and cyberbullying), and feelings about school and teachers
Change from baseline to 6 months follow up
Change from Baseline to 6 months follow up; the Brief resilience scale - parent report (parental resilience)
Time Frame: Change from baseline to 6 months follow up; experience of the current resilience
Comprises of six items assessing resilience; scoring 6-36 (higher score meaning higher resilience)
Change from baseline to 6 months follow up; experience of the current resilience
Change from Baseline to 6 months follow up; the Depression Anxiety and Stress Scale Short Form - parent report (parental depression, anxiety and stress)
Time Frame: Change from baseline to 6 months follow up; symptoms during the last week
Comprises of 21 items assessing parental depression, anxiety and stress; scoring 0-63 (higher score meaning more symptoms)
Change from baseline to 6 months follow up; symptoms during the last week
Change from Baseline to 6 months follow up; the Customised Client Receipt Inventory Questionnaire - parent report
Time Frame: Change from baseline to 6 months follow up; service use during the last six months
Assesses the child's use of school support services, and social and health care services
Change from baseline to 6 months follow up; service use during the last six months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 24, 2017

Primary Completion (Actual)

December 15, 2020

Study Completion (Actual)

December 15, 2020

Study Registration Dates

First Submitted

September 30, 2017

First Submitted That Met QC Criteria

October 9, 2017

First Posted (Actual)

October 16, 2017

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 16, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ANXIETY-2017

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on Digitalized cognitive-behavioral intervention for anxiety

3
Subscribe